CDMO Dossier

CDMO site sources and review dates

Full fact IDs, candidate hashes, and SHA-256 snapshot hashes are retained in 03-aggregate/dependents.json and 03-aggregate/snapshots/manifest.json.

Sources for the added answers

Download the added facts (JSON)

AGC Biologics · Seattle Site Overview

Open primary source ↗

Read 2026-11-14T03:58:35.926821+00:00 · Vendor documentation · Named Seattle facility and mammalian equipment. No open campaign slots or independent inspection result.
Saved capture SHA-256: cd6943eda0c06fc59b7b0e8c8b03f660463507108780e563cf0324cc69ac8608

Passages used
  • protein biologic ds scope: L143–L153; L182–L185
  • installed bioreactor scale: L182–L199

FUJIFILM Biotechnologies · Holly Springs manufacturing announcement, July 8, 2026

Open primary source ↗

Read 2026-11-14T03:58:35.926821+00:00 · Vendor documentation · Vendor announcement. Current 8-reactor figure kept separate from targeted future expansion; no FDA approval inferred from PreCheck participation.
Saved capture SHA-256: a2ed31953752e95898200ea09c6190cad1e45e9f61b4ccd909c7c6cd7d6e8396

Passages used
  • protein biologic ds scope: L85–L94
  • installed vs planned scale: L94–L95

Avid Bioservices · Costa Mesa Early Phase Center

Open primary source ↗

Read 2026-11-14T03:58:35.926821+00:00 · Vendor documentation · Facility-specific development scope, not evidence of commercial manufacture at Costa Mesa.
Saved capture SHA-256: a63410c0a6c532d84adcb52dabce7fbd9df12d44dca706829c1bfe85871cc460

Passages used
  • protein biologic ds scope: L66–L93

Avid Bioservices · About Avid: Two California Campuses

Open primary source ↗

Read 2026-11-14T03:58:35.926821+00:00 · Vendor documentation · Named early-phase vs clinical/commercial campus distinction; capacity slots and quality history unverified.
Saved capture SHA-256: fdcdf2d3284f5ffb11231a0c507892f0305a37ed732ded2d427e6c250674ac35

Passages used
  • clinical commercial stage: L104–L115